GSK-690693

N/A

Report date: 2023/03/20 14:51:25

NME

Base Information

Drug NameGSK-690693

Drug Alias NameGSK-690693

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitorsSerine/threonine-protein kinase AKT2 inhibitorsSerine/threonine-protein kinase AKT3 inhibitors

TargetsSerine/threonine-protein kinase AKT2Serine/threonine-protein kinase AKT3Serine/threonine-protein kinase AKT1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A